Mouse Anti-KRT5 Recombinant Antibody (CBT2762) (V2LY-0625-LY2779)









Basic Information
Application | Note |
WB | 1:500-1:2,000 |
IHC-P | 1:200-1:1,000 |
ICC | 1:200-1:1,000 |
FC | 1:200-1:400 |
ELISA | 1:10,000 |
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Cytosol
Extracellular exosome
Intermediate filament
Keratin filament
Membrane
Nucleus
A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering and cleavage within basal keratinocytes, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma.
Epidermolysis bullosa simplex, Dowling-Meara type (DM-EBS):
A severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement.
Epidermolysis bullosa simplex, with migratory circinate erythema (EBSMCE):
A form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping.
Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS):
A form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin.
Epidermolysis bullosa simplex, Koebner type (K-EBS):
A form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, although it is less severe.
Epidermolysis bullosa simplex, with mottled pigmentation (MP-EBS):
A form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules.
Dowling-Degos disease 1 (DDD1):
An autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-KRT5 Recombinant Antibody (1A8) (CAT#: CBMAB-K1884-LY)
Mouse Anti-KRT5 Recombinant Antibody (CBXC-2843) (CAT#: CBMAB-C0188-CQ)
Mouse Anti-KRT5 Recombinant Antibody (4H8) (CAT#: CBMAB-K1908-LY)
Mouse Anti-KRT5 Recombinant Antibody (CBT3163) (CAT#: V2LY-0625-LY413)
Mouse Anti-KRT5 Recombinant Antibody (CBT430) (CAT#: V2LY-0625-LY3534)
Mouse Anti-KRT5 Recombinant Antibody (CBT4666) (CAT#: V2LY-0625-LY2194)
Mouse Anti-KRT5 Recombinant Antibody (AT12C4) (CAT#: CBMAB-C3860-CN)
Mouse Anti-KRT5 Recombinant Antibody (16-04-14) (CAT#: CBMAB-K1894-LY)
Mouse Anti-KRT5 Recombinant Antibody (RCK102) (CAT#: CBMAB-C1003-CQ)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
